GCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

End-To-End Spectroscopy-Based Workflow Solutions for Oligonucleotide Analysis

Brochures and specifications | 2023 | Agilent TechnologiesInstrumentation
GC, GC/MSD, HeadSpace, GC/SQ, Software, HPLC, RAMAN Spectroscopy, UV–VIS spectrophotometry, ICP/MS, FTIR Spectroscopy
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies

Summary

Importance of the Topic


Oligonucleotides play an increasingly vital role in research, diagnostics and therapeutic development. Ensuring their identity, purity and concentration supports reproducible results, regulatory compliance and patient safety. Advanced spectroscopy and chromatography workflows deliver rapid, robust characterization from raw materials through final product QA/QC under Good Manufacturing Practices.

Aims and Overview of the Study


This resource guide presents end-to-end analytical solutions tailored for oligonucleotide analysis. It outlines workflows for raw material verification, finished product confirmation, impurity profiling and solvent residue testing. The primary objective is to demonstrate integrated, high-throughput methods that satisfy regulatory requirements and streamline laboratory operations.

Methodology and Instrumentation


The guide describes four main analytical workflows:
  • Raw Material Identification: Raman spectroscopy (handheld Agilent Vaya), FTIR (Cary 630) and LC-UV (1290 Infinity II Bio LC) detect and confirm incoming reagents before synthesis.
  • Finished Product Identification: UV-Vis spectroscopy (Cary 3500 Multizone) measures nucleic acid concentration at 260 nm and performs thermal melt analyses to verify duplex stability.
  • Trace Elemental Impurity Analysis: ICP-MS (Agilent 7850/7900) following ICH Q3D/USP <233> guidelines quantifies toxic metals in drug substances with high sensitivity and accuracy.
  • Residual Solvent Analysis: GC and GC/MS (8890 GC, 5977C MSD with 8697 Headspace) comply with USP <467> using routine, high-throughput and unknown screening approaches.

Key instrumentation includes Agilent Vaya Raman spectrometer, Cary 630 FTIR, 1290 Infinity II Bio LC, Cary 3500 UV-Vis, 7850 ICP-MS, 8890 GC system, 5977C GC/MSD and associated autosamplers and software platforms.

Main Results and Discussion


Each workflow demonstrated rapid identification and quantitation with minimal sample preparation. Raman and FTIR correctly classified raw reagents in transparent and opaque containers. UV-Vis assays delivered precise nucleic acid quantification and reliable melting temperatures. ICP-MS workflows achieved detection limits below regulatory thresholds, while GC/GC-MS methods provided comprehensive residual solvent profiles according to USP requirements. Integrated software solutions ensured data integrity and streamlined reporting.

Benefits and Practical Applications


These workflows enhance laboratory efficiency by reducing analysis time and simplifying data review. They support cGMP compliance, minimize risk of mislabeling or contamination, and provide actionable results for research, clinical oligonucleotide production and quality control environments.

Future Trends and Potential Applications


Future developments may include further automation, real-time process monitoring, integration of hyphenated techniques and application of machine learning for predictive impurity profiling. Advances in miniaturized instrumentation and higher-throughput sample handling will continue to accelerate oligonucleotide analytics.

Conclusion


The presented end-to-end spectroscopy and chromatography workflows deliver robust analytical performance for oligonucleotide characterization. By combining validated instrumentation with secure software, laboratories can achieve efficient QC, comply with regulatory standards and support innovation in nucleic acid therapeutics and diagnostics.

Reference


Selected references in standard format:
  • Neo A., Welsby C. Rapid Testing of Solvents Through Amber Bottles Using an Agilent Vaya Handheld Raman Spectrometer. Agilent Technologies Application Note 5994-5929EN (2023).
  • Agilent Technologies. Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS. Application Note 5994-6470EN (2023).
  • Sanderson J. Residual Solvent Analysis in Hemp Consumer Products Using Headspace Gas Chromatography and Mass Spectrometry. Application Note 5994-5237EN (2022).
  • Alwan W., Zieschang F. The Agilent Cary 630 FTIR Spectrometer for Material Identification Applications. Application Note 5994-4992EN (2022).

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
End-To-End Workflow Solutions for Therapeutic Peptides
End-To-End Workflow Solutions for Therapeutic Peptides
2025|Agilent Technologies|Brochures and specifications
Therapeutic Peptides Workflow Resource Guide End-To-End Workflow Solutions for Therapeutic Peptides From research discovery to production QA/QC Ensuring Quality in Therapeutic Peptide Development Peptides are short chains of amino acids, which are the "building blocks" of proteins. Some peptide molecules…
Key words
peptide, peptideopenlab, openlabbundle, bundlesoftware, softwareworkflow, workflowadvancebio, advancebiochemstation, chemstationmsd, msdpreparative, preparativeagilent, agilentanalysis, analysisvaya, vayadetect, detectimpurity, impuritypurification
Driving the Field of Oligonucleotide Therapeutics
Image © Agilent Technologies, Inc. 2024 Sponsored by Driving the Field of Oligonucleotide Therapeutics State-of-the-Art Solutions for Oligonucleotide Characterization, Purification, and Manufacturing / Chapter 1: Introduction to Oligonucleotide Therapeutics / Chapter 2: Challenges for Oligonucleotide Synthesis and Production / Chapter…
Key words
labx, labxebook, ebookoligonucleotide, oligonucleotidebio, biooligos, oligosoligonucleotides, oligonucleotidesoligo, oligopurification, purificationanalysis, analysisagilent, agilentsynthesis, synthesisimpurities, impuritiespreparative, preparativesynthetic, syntheticpurity
Agilent Molecular Spectroscopy Solutions For the pharmaceutical and biopharmaceutical industries
Agilent Molecular Spectroscopy Solutions For the pharmaceutical and biopharmaceutical industries Analytical Workflows for Drug Discovery, Drug Development, and Drug Manufacturing Agilent’s innovative molecular spectroscopy products are designed to meet the application requirements that are critical for pharmaceutical and biopharmaceutical laboratories.…
Key words
vaya, vayacary, caryraman, ramanfluorescent, fluorescentsors, sorsmeggle, megglecuvettes, cuvettesprotein, proteinmonohydrate, monohydratesack, sackfluorescence, fluorescencespectroscopy, spectroscopylactose, lactosestudies, studiesyour
Workflow Solutions for Peptide Therapeutics - Application Compendium
Workflow Solutions for Peptide Therapeutics Application Compendium Table of Contents Introduction4 An emerging class of peptide therapeutics: GLP-15 Analytical advances in peptide therapeutics5 Key analyses for synthetic and recombinant peptide therapeutics 6 Types of impurities in peptide therapeutics 7 Agilent…
Key words
peptide, peptidereturn, returncontents, contentsadvancebio, advancebiotable, tableliraglutide, liraglutideagilent, agilentanalysis, analysisinfinitylab, infinitylabsemaglutide, semaglutideimpurities, impuritiessynthetic, syntheticmsd, msdtherapeutics, therapeuticsnotes
Other projects
LCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike